2021 in Review and What ’ s Next
9
“ Denali and Biogen now have the information that will help them pick the doses for their next trials that will hopefully be safe and may be successful in slowing disease . This is an exciting step .”
— Marco Baptista , PhD , Vice President of Research Programs , The Michael J . Fox Foundation